Yvonne Efebera

Yvonne Efebera, MD

Physician

Make an Appointment

Specialty

Overall Patient Satisfaction Rating

stars
4.8 out of 5
61
Reviews
3
Comments

Gender

Female

Language

Krio

Biography


My clinical focus at the OSUCCC – James is B-cell lymphoid malignancies, including multiple myeloma, amyloidosis, Waldenstrom's disease and stem cell and bone marrow transplant. I also serve as an associate professor of internal medicine for The Ohio State University. I was named to the Castle Connolly list of “Regional Top Doctors” in 2019, as well as being rated in the top 10 percent of physicians in the nation for patient satisfaction in 2014 and 2017.

I regard my patients as part of my family. When I discuss their treatment with them, I often say that if they were my sister, my father or my mother I would recommend the same treatment. Every one of my patients knows they have a physician who deeply cares and has done her best to help them.

I’m also very passionate about research, and I study novel therapies for treating multiple myeloma and graft-versus-host disease (GVHD). The latter is a complication that can occur after a stem cell or bone marrow transplant in which the transplanted cells attack the body, often resulting in a serious illness.

One of the best things about working at The James is being surrounded by such outstanding scientists and clinicians. Everyone here is an expert in his or her area, and that in turn inspires me to become a better and more effective physician.

Education and Background

Education

Pennsylvania State University College of Medicine

Hershey, PA

Residencies

Cleveland Clinic Foundation

Cleveland, OH

Fellowship

Hematology/Oncology

Boston Medical Center

Boston, MA

Bone Marrow Transplant

MD Anderson Cancer Center

Houston, TX

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine (Subspecialty: Medicine Oncology)

Academic Department

Department of Internal Medicine

Division of Hematology


Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Efebera has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

Karyopharm Therapeutics Inc.

Janssen Research

Takeda Pharmaceutical Company

Reviews

Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 61 reviews)
stars
4.8 out of 5
Kept you informed about your condition and treatment

4.8/ 5

Amount of time spent with you

4.8/ 5

Concern for your questions and issues

4.9/ 5

Skill and knowledge

4.9/ 5

Overall quality of care

4.9/ 5

Patient Comments (3 total comments)

stars
Reviewed: 4/26/2019

Dr. Efebera listened to my concerns about a string of recent sinus infections. She referred me to an Ohio State ENT at my request. I had an ENT appointment scheduled before I left the offices. Dr. Efebera is amazing!!

stars
Reviewed: 1/22/2019

I have been so grateful to receive such excellent care from my doctors at The James. Phenomenal team!

stars
Reviewed: 1/18/2019

Excellent care and concern

Publications

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Yucebay F, Matthews C, Puto M, Li J, William B, Jaglowski SM, Penza SL, Vasu S, Benson DM, Andritsos LA, Devine SM, Efebera YA, Roddy JVF

Leuk Lymphoma in press

2/15/2019

BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas.

Singer S, Sharma N, Dean R, Zhao Q, Abounader D, Elder P, Hofmeister CC, Benson DM, Rosko A, Penza S, Andritsos L, Vasu S, Jaglowski S, William BM, Bolwell B, Pohlman B, Kalaycio M, Jagadeesh D, Hill B, Sobecks R, Devine SM, Majhail NS, Efebera YA

Bone Marrow Transplant in press

2/4/2019

Clinical Trials | Lead

OSU-15270

BMT-CTN1703

OSU-18288

Back to Find a Doctor Search

Make an Appointment

800-293-5066

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Please enter a keyword (i.e. Name, Location) or choose a Cancer Type

OR